Introduction
The generation and maintenance of functional 3'-ends of tRNAs is important for protein translation and cell survival in all organisms. This is accomplished by ATP(CTP):tRNA nucleotidyltransferase, which catalyzes the addition of the trinucleotide CCA to the 3'-OH terminus of tRNAs in a template-independent way. This enzyme is not essential
Results

Identification of a Putative Human tRNA Nucleotidyltransferase
To search for a homologous tRNA nucleotidyltransferase in humans, the amino acid sequence of tRNA nucleotidyltransferase from S. cerevisiae (Aebi et al., 1990) was used as a query in a BLAST search (Altschul et al., 1990) of human DNA sequences in the NCBI database. The predicted 405 amino acid sequence of the human mRNA CGI-47 (accession no. AF151805) exhibited substantial similarities to the yeast homolog and to other known or putative tRNA nucleotidyltransferases and poly(A) polymerases (data not shown). The CGI-47 protein contains the active site signature (including two highly conserved aspartate residues, D 48 and D 50 ) for members of the nucleotidyltransferase family (Holm and Sander, 1995) and can be further classified as a class II nucleotidyltransferase according to Yue et al. (1996) . Taken together, the overall conservation of amino acids in the N-terminal part of eubacterial and eukaryotic tRNA nucleotidyltransferases and the CGI-47 protein suggests the latter most likely to be either the human tRNA nucleotidyltransferase or poly(A) polymerase.
Overexpression and Purification of His-Tagged CGI-47 Protein
In order to determine whether the CGI-47 protein has the enzymatic activity of a tRNA nucleotidyltransferase, a poly(A) polymerase, or another sort of nucleotidyltransferase, we proceeded with cloning of the gene and overexpression and characterization of its product.
The full-length coding sequence was obtained by RT-PCR from total HeLa RNA and cloned into a pET30Ek/Lic vector. Overexpression of the His-tagged CGI-47 protein in E. coli BL21 CodonPlus (DE3)-RP cells was induced with 1 mM IPTG. Samples were taken before induction and one, two and three hours thereafter ( Figure 1A , lanes 2, 3, 4, and 5, respectively). A prominent band at apparent molecular weight of about 45 000 absent before induction is visible already one hour after induction and increases steadily until three hours after induction ( Figure  1A ). This corresponds approximately to the expected size of 51 kDa for the His-tagged CGI-47 gene product. The crude bacterial extract was loaded onto a His•Bind Quick 900 cartridge (Novagen, Madison, USA), washed with 5 mM imidazole containing buffer, washed additionally with 60 mM imidazole buffer and eluted finally with 1 M imidazole buffer. Aliquots of the washing and elution fractions were separated on a 10% SDS polyacrylamide gel and proteins were visualized by staining with Coomassie Brilliant Blue ( Figure 1B) . A majority of the recombinant His-tagged CGI-47 protein with an apparent molecular weight of 45 000 already elutes in the 60 mM imidazole washing step along with some impurities (Figure 1B, lane 6) , while the eluate at 1 M imidazole contains only minor impurities ( Figure 1B, lanes 8, 9) . Therefore, the fraction shown in lane 9 was used for further experiments after desalting.
In Vitro Nucleotide Incorporation Activity of CGI-47 Protein
To test whether the purified recombinant protein has nucleotide incorporating activity, an in vitro nucleotide incor- (A) Overexpression of the His-tagged CGI-47 protein in E. coli BL21 CodonPlus (DE3)-RP cells was induced with 1 mM IPTG. Samples were taken before induction and one, two and three hours thereafter (lanes 2, 3, 4, 5, respectively). (B) The overexpressed protein was affinity-purified using a His•Bind Quick 900 cartridge (Novagen). The bacterial extract was loaded onto the cartridge (lane 1), washed with 5 mM imidazole containing buffer (lanes 2 -5), further washed with 60 mM imidazole containing buffer (lanes 6, 7) and finally eluted with 1 M imidazole containing buffer (lanes 8 -11). Aliquots of the washing and elution fractions were separated using 10% SDS PAGE and proteins were visualized by staining with Coomassie Brilliant Blue. Protein from fraction in lane 9 was used for further experiments. poration assay was used (Reichert et al., 1998) . A 5'-endlabeled chimpanzee mitochondrial tRNA Tyr substrate was incubated in the presence of all four NTPs for up to 24 h at 30 °C with the recombinant CGI-47 protein. The products were analyzed by denaturing PAGE and autoradiography. In the presence of recombinant CGI-47 protein, incorporation of three nucleotides was observed within one hour (Figure 2, lane 4) . The intensity of shifted tRNA molecules increases up to six hours of incubation but remains almost unaltered after that (Figure 2, lanes 5 -7) . As a positive control (Figure 2, lane 2) , a human mitochondrial protein extract was used which was shown to incorporate three nucleotides corresponding to the expected CCA addition (Reichert et al., 1998; Reichert and Mörl, 2000) . In order to prove that the observed nucleotide incorporating activity originates from the recombinant CGI-47 protein and not from endogenous E. coli impurities, we obtained in parallel a control protein extract from the same E. coli strain carrying a pET30Lic/Ek control plasmid lacking the CGI-47 coding sequence. Comparable amounts of the extract did not show any nucleotide incorporation even after 24 hours ( Figure 2 , lane 8).
Enzyme Kinetics of the CGI-47 Protein
The kinetics of ATP and CTP incorporation reactions of the CGI-47 protein were investigated using the purified enzyme preparation with a specific activity of 65 000 units/mg protein (1 unit equals the incorporation of 1 nmol AMP in 1 h at 37 °C). The addition of radioactive A Eubacterial Human tRNA Nucleotidyltransferase? 1433 The latter was obtained in parallel to His 6 -CGI47 protein using exactly the same protocol for overexpression and His•Bind-purification but starting from an E. coli BL21-CodonPlus™ (DE3)-RP strain carrying a pET30 Lic/EK plasmid with an 32 bp control insert. Incubation was performed for 24 hours at 30 °C if not indicated otherwise. AMP or CMP onto bulk E. coli tRNA partially missing the CCA-terminus was monitored at varying nucleotide concentrations. Initial velocities follow Michaelis-Menten kinetics for AMP and CMP incorporation (Figure 3) , and based on two independent experiments give average K m values of 605 M and 20 M, respectively. The k cat was calculated to be 0.8 s -1 . These values are comparable to those known from other tRNA nucleotidyltransferases (Deutscher, 1982) . Therefore, we conclude that the CGI-47 protein indeed represents a human tRNA nucleotidyltransferase and not a poly(A) polymerase.
Identification of Homologous tRNA Nucleotidyltransferases in C. elegans, D. melanogaster and M. musculus
Using the human tRNA nucleotidyltransferase as a query sequence in a BLASTP search, we obtained candidates 1434 A.S. Reichert et al. from Caenorhabditis elegans (CAB02125), Drosophila melanogaster (AAF51964) and Mus musculus (AK011764) showing 42% (180/425 amino acids), 49% (201/404 amino acids), and 94% (247/261 amino acids) aminoacid identity, respectively. In addition, a second entry of the human CGI-47 sequence (XM_002866) was present in the database showing an N-terminal extension of 29 amino acids, and being otherwise 100% identical to the CGI-47 protein. Interestingly, this extension is predicted to serve as a cleavable mitochondrial targeting sequence by the program MITOPROT (Claros and Vincens, 1996) . The Drosophila homolog also appears to contain an N-terminal mitochondrial targeting sequence, while those from mouse or C. elegans do not. The mouse homolog was derived from a cDNA clone and no function was assigned to it in the NCBI database. The fruit fly and the C. elegans homologs are predicted proteins from the respective complete genome sequences and have been assigned to the poly(A) polymerase family. Nevertheless, it remains unclear whether these proteins are poly(A) polymerases or tRNA nucleotidyltransferases or another member of the nucleotidyltransferase superfamily. At least for the mouse sequence the close similarity to the human tRNA nucleotidyltransferase is striking, as judged by the sequence alignment including protein sequences from Saccharomyces cerevisiae, Schizosaccharomyces pombe, Arabidopsis thaliana, Lupinus albus, Rickettsia prowazekii, Bacillus subtilis and Escherichia coli (Figure 4 ).
All homologs have the active site signature (underlined in Figure 4 ) of the nucleotidyltransferase family identified by Holm and Sander (1995) at positions 34 -51 (Hsa), which classifies them as class II nucleotidyltransferases (Yue et al., 1996) .
In summary, based on the aforementioned biochemical characterization of the human CCA-adding enzyme and the close similarity to this enzyme, we suggest that the mouse, the fruit fly and the C. elegans homologs most likely represent tRNA nucleotidyltransferases in these organisms.
Discussion
CGI-47 Is a CCA-Adding Enzyme, Not a Poly(A) Polymerase
Following an analysis of sequence alignments of known or suspected tRNA nucleotidyltransferases and a BLASTP search using the yeast enzyme as a query, we hypothesized that the CGI-47 protein is either the human poly(A) polymerase or the CCA-adding enzyme. This hypothesis was tested by cloning and overexpression of the corresponding gene in E. coli, and by purification and characterization of the gene product. The overexpression system yielded a protein with an additional N-terminal cleavable 43 amino acid His•Tag and S•Tag for detection and purification. Although the expected size of the fusion protein is 51 kDa, a major protein product with an apparent molecular weight of about 45 000 was observed after induction ( Figure 1A ). The nucleotide sequence of the cloned insert was confirmed, so the slightly increased electrophoretic mobility in the SDS-PAGE seems to represent a migration artifact. Nevertheless, the enzyme is highly purified as judged by the nearly complete absence of other bands in the gel ( Figure 2B, lane 9 ). An in vitro nucleotide incorporation assay (Figure 2 ) revealed that the protein is able to add three nucleotides into an in vitro transcribed tRNA substrate missing the CCA-terminus, indicating that the CGI-47 protein is not a poly(A) polymerase but a bona fide tRNA nucleotidyltransferase. Although only two shifted bands are visible, it is evident that these represent tRNA-CC and tRNA-CCA for the following reasons. First, earlier experiments showed that a human mitochondrial S100 extract, which exhibits the same pattern of reaction product bands as the CGI-47 protein (Figure 2, lane 2) , adds three nucleotides (CCA) to this tRNA substrate (Reichert et al., 1998; Reichert and Mörl, 2000) . Secondly, using less enzyme an additional band, presumably representing tRNA-C, between the tRNA substrate and the proposed tRNA-CC band was observed (data not shown). Furthermore, one can rule out the possibility that the observed activity results from contaminating endogenous E. coli CCA adding enzyme, because a control extract prepared in the same way but missing the CGI-47 gene insert in the cloning vector gave no nucleotide incorporation even after 24 hours of incubation (Figure 2, lane 8) .
Another line of biochemical evidence that CGI-47 is a tRNA nucleotidyltransferase comes from the kinetic characterization of the recombinant protein, showing K m values for ATP of 605 M and for CTP of 20 M. These values are comparable to those from other organisms in terms of absolute and relative magnitudes (i. e., that for ATP being substantially higher than that for CTP). For example, the enzyme from Sulfolobus shibatae has an apparent K m for ATP of higher than 200 M and for CTP of 30 M (Yue et al., 1996) .
In summary, the CGI-47 protein represents the first example of an animal CCA-adding enzyme whose sequence is known and which has been characterized biochemically. Since it is not possible to identify the nature and enzymatic properties of a member of the nucleotidyltransferase family solely by sequence comparison, the enzymatic assays provide the only possibility to distinguish between a true tRNA nucleotidyltransferase and a very similar (in terms of sequence) poly(A) polymerase. Therefore, on the basis of our results, we suggest renaming the human CGI-47 protein as a tRNA nucleotidyltransferase.
In order to identify additional enzymes of this class, the human protein sequence was used in a BLASTP search. In addition to homologs in mouse, D. melanogaster, and C. elegans a second human sequence (XM_002866) was obtained from the NCBI database. This protein sequence differs from the first CGI-47 sequence (AF151805) by an additional N-terminal mitochondrial targeting sequence of 29 amino acids. Therefore, it is likely that this protein is a mitochondrial tRNA nucleotidyltransferase. If this was the case, it would be possible that the cytoplasmic and the mitochondrial tRNA nucleotidyltransferase originate from the same gene CGI-47 on chromosome 3pter-3p25.1, as was shown to be the case in yeast where one gene encodes for two versions of the enzyme by alternative initiation of translation (Chen et al., 1992; Wolfe et al., 1996) . Whether this is also true for humans remains to be determined. One could also imagine that alternative splicing or RNA editing results in different mRNAs coding for these gene products. This idea is supported by the observed sequence differences of the cDNA clones (ESTs) which result from two human full-length mRNA sequences (AF151805 and XM_002866) using different start codons. However, we cannot say at this point whether the sequence differences are due to sequencing errors in the original ESTs or are due to real differences in the transcripts caused by alternative splicing or RNA editing. Furthermore, one cannot exclude the possibility that the nuclear gene encoding the cytoplasmic version of this enzyme has not been detected yet.
The alignment of the N-terminal region of known and newly identified homologs of tRNA nucleotidyltransferases ( Figure 4 ) reveals all enzymes to be members of the class II of the nucleotidyltransferase superfamily according to Yue et al. (1996) . In this region, two highly conserved aspartate residues (Hsa, D 48 , D 50 ; bold and underlined in Figure 4) are part of the active site. Homologous aspartate residues in members of class I nucleotidyltransferases are involved in metal ion coordination (e. g. rat DNA polymerase Sawaya et al., 1994) . They have also been shown by mutagenesis experiments to be required for catalysis in both poly(A) polymerase (Martin and Keller, 1996) and tRNA nucleotidyltransferase (Yue et al., 1998) , demonstrating again the impossibility to predict enzymatic activities in the nucleotidyltransferase superfamily on the basis of protein sequences. Also the conserved RRD-motif (Figure 4 ) common to most class II nucleotidyltransferases (Yue et al., 1996) is present in all sequences. It is thought to contain the third catalytic aspartate (Hsa, D 123 ) and has also homologs in CCA-adding enzymes (D 106 , Thurlow et al., 1997) as well as in poly(A) polymerases (D 167 , Martin et al., 1999) . Another region of particular interest spans positions [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] . This has been identified as a highly conserved region, even among archaeal tRNA nucleotidyltransferases, which possibly can adopt an amphipathic -helix (Thurlow et al., 1997) . It has also been suggested that this region is involved in nucleotide binding in poly(A) polymerases (Martin et al., 1999) . Mutagenesis experiments with the yeast CCA-enzyme confirm this notion (D. L. Thurlow, unpublished results).
Evolution of Animal tRNA Nucleotidyltransferases
Based on the sequence alignment in Figure 4 we calculated an unrooted neighbor-joining tree (Saitou and Nei, 1987) shown in Figure 5 . Although the number of sequences used to construct the tree is rather small, several interesting trends emerge. Surprisingly, the animal CCA-adding enzymes are most closely related to that from Rickettsia prowazekii and resemble more the eubacterial enzymes from E. coli and B. subtilis than the eukaryotic fungal and plant CCA-adding enzymes. The distinction between the animal and plant/fungal groups of enzymes is readily apparent by visual inspection of the sequence alignments (Figure 4) .
Mitochondria are believed to originate from an -proteobacterium of the Rickettsia subgroup by endosymbiosis (Gray et al., 1999) , suggesting that the animal nuclear cca genes may have been derived from this endosymbiont and encode at least for the mitochondrial CCAadding enzymes in these organisms. Thus, it is feasible that the cca gene was transferred to the nucleus early in animal evolution. However, it is not known whether they have replaced the corresponding eukaryotic gene coding for the nuclear and cytoplasmic tRNA nucleotidyltransferase or whether the latter has not been identified yet (see above). At least for the Drosophila and the human homologs, a mitochondrial targeting sequence has been identified, thereby directing the gene product back to mitochondria. In contrast, the plant and fungal CCA-adding enzymes identified so far form a discrete cluster clearly separated from the animal enzymes and do not seem to have originated from this endosymbiotic event.
Taken together, these results suggest that animal tRNA nucleotidyltransferases (including the human enzyme) are likely to have been derived from enzymes that were taken over by the eukaryotic host of the mitochondrial progenitor.
Materials and Methods
Cloning and Overexpression
Using total RNA prepared from HeLa cells (a gift from Wolfgang Enard and Florian Heissig) cDNA was prepared using Oligo(dT) priming and Superscript II reverse transcriptase according to the supplier (Gibco/BRL, Rockville, USA). The full-length coding sequence (1218 bp) was PCR amplified (2 min at 94 °C; 30 cycles 1 min at 94 °C/1 min at 50 °C/3 min at 72 °C; 5 min at 72 °C) with the following primers: hscca1 (5'-GAC GAC GAC AAG ATG AAG TTG CAG TCT CCC G-3') and hscca2 (5'-GAG GAG AAG CCC GGT TAG GTC TTC TTT ATG TAA CTC-3'). The PCR product was cloned into pET30 Ek/Lic according to the supplier (Novagen, Madison, USA) . This resulted in a construct with additional 43 N-terminal cleavable amino acid (His•Tag and S•Tag). Initial transformation was performed by electroporation into E. coli TOP10 One Shot cells according to the supplier (Invitrogen, Carlsbad, USA). Subsequently, the plasmid DNA from a positive clone was transformed into E. coli BL21-CodonPlus (DE3)-RP for overexpression. DNA sequencing of this plasmid DNA on an ABI Prism 377 automated sequencer confirmed the deposited sequence with the exception of two silent mutations (TTT TTC, coding for Phe 111 and GCG GCA, coding for Ala 287 ). An overnight culture of E. coli BL21-CodonPlus™ (DE3)-RP/pET30 Lic/EK-hscca#7 cells was used to inoculate 250 ml LB supplemented with kanamycin (30 g/ml) and chloramphenicol (34 g/ml). The culture was grown at 37 °C (120 rpm shaking) to an OD 600nm of 1.0. Expression of the recombinant human tRNA nucleotidyltransferase was then induced by the addition of IPTG to a final concentration of 1 mM. After three hours of induction, the cells were left on ice for five minutes and subsequently harvested by centrifugation at 5000 g for 10 minutes at 4 °C. The bacterial pellet was stored at -80 °C until use. Affinity purification of the recombinant His-tagged protein was done according to the supplier using the His-Bind Kit (Novagen): the cells were thawed on ice and resuspended in 4 ml binding buffer (5 mM imidazol, 0.5 M NaCl, 20 mM Tris/Cl pH 7.9) and sonicated with a MS-73mm tip on a Sonopuls HD 2070 sonicator (Bandelin, Berlin, Germany) 10 times each for 15 s on ice. The volume was adjusted to 15 ml and centrifuged (20 min, 18000 rpm in a SS-34 rotor, 39000 g, 4 °C). An aliquot (2 ml) of the supernatant was loaded onto an equilibrated His•Bind Quick 900 cartridge. After washing with 20 ml binding buffer and 10 ml wash buffer (60 mM imidazole, 0.5 M NaCl, 20 mM Tris/Cl pH 7.9) the His-tagged protein was eluted with elution buffer (1 M imidazole, 0.5 M NaCl, 20 mM Tris/Cl pH 7.9) in four fractions, each containing 1 ml. Before assaying the fractions for activity they were desalted with G25 microspin columns (Amersham Pharmacia Biotech, Freiburg, Germany) equilibrated in 20 mM HEPES/KOH (pH7,9), 1 mM DTT.
Preparation of Substrate tRNA
The template for in vitro transcription was prepared by PCR amplification (2 min at 94 °C; 30 cycles 1 min at 94 °C/1 min at 50°C/30 s at 72 °C) of the corresponding mitochondrial gene using the following primers: T7(chimpTyr): 5'-CTAATACGACTCACTATAGGTAAAATGGCT-GAG-3'. Downstream(chimpTyr): 5'-TGGTAAAAAGAGGCTTAA-3'. Transcription with T7 RNA polymerase (New England Biolabs, Schwalbach, Germany), dephosphorylation using calf intestinal alkaline phosphatase (New England Biolabs) and 5'-end-labeling using polynucleotide kinase (New England Biolabs) and [ -33 P]-ATP (Amersham Pharmacia Biotech, Freiburg, Germany) were carried out according to the supplier. Radioactively labeled transcripts or reaction products were separated and purified by denaturing polyacrylamide gel electrophoresis (Peattie, 1979) .
In Vitro Nucleotide Incorporation Assay
5'-[
33 P]-labeled tRNA substrate (1 -10 pmol) was incubated with 45 ng of highly purified human CGI-47 protein in the presence of 1 mM NTPs, 30 mM HEPES-KOH (pH 7.6), 6 mM MgCl 2 , 30 mM KCl, 2 mM DTT and 30 U RNase inhibitor (Roche Molecular Biochemicals, Mannheim, Germany) in a total volume of 20 µl for up to 24 hours at 30 °C. After ethanol precipitation, the products were separated by electrophoresis on a 10% polyacrylamide gel containing 8 M urea and visualized by autoradiography.
Enzyme Assays
The standard assay (15 l) contained 50 mM glycine (pH 9.4), 20 mM MgCl 2 , 1 mM dithiothreitol (DTT), 30 M tRNA, and ATP or CTP (5 -1000 M). The tRNA substrate was total tRNA of E. coli (Sigma, St. Louis, USA), from which the CCA sequence had been partially removed (Deutscher, 1972a) by treatment with snake venom phosphodiesterase (Worthington Chemical, Freehold, USA). Addition of AMP or CMP onto intact tRNA was monitored by including 0.33 M [ -32 P]-ATP or [ -32 P]-CTP (3000 Ci per mmol; ICN Pharmaceuticals Inc., Costa Mesa, USA). For titration of NTP, 30 M tRNA and NTP at final concentrations ranging from 5 -1000 M were used, and 100 M unlabeled CTP was included for the ATP titration. Following pre-incubation at 37°C for 30 s, the reaction was initiated by adding enzyme (0.032 M) and was continued for 5 min at 37 °C. The reaction was stopped by adding 5 l of formamide containing 0.025% xylene cyanole and 0.025% bromophenol blue and transfering the reaction to ice. The mixture was loaded onto a denaturing 10% polyacrylamide gel (acrylamide:N,N'-methylene bisacrylamide:19:1) in 100 mM Tris-borate (pH 8.3), 2.5 mM EDTA, and 8 M urea. Intact [ 32 P]-labeled tRNA was visualized by autoradiography, sliced from the gel, and counted in liquid scintillation cocktail using a Packard 1900CA liquid scintillation counter. Specific activities of the labeled NTP were used to convert radioactivity in gel slices to moles of incorporated nucleotide. They were determined by counting an aliquot of the incubation mix polymerized into pieces of polyacrylamide, comparable in size and thickness to slices from the assay gel, and dividing this measured amount of radioactivity by the amount of total NTP in the same volume of incubation mix. All radioactivity measurements were corrected for decay to the manufacturer's assay date of the isotope.
Apparent Michaelis-Menten constants (K m ) and maximum velocities (V max ) were calculated using a least-squares curve fit to the Michaelis-Menten equation (Kaleidagraph, Ablebeck Software), and statistically, assuming that each measured initial velocity is subject to the same proportion of random error (Cornish-Bowden and Wharton, 1988) . Both approaches gave similar estimates, and kinetic constants are reported as the average of calculated values for all titrations using both approaches ± one standard deviation from the mean. The calculated value of V max M/s) was divided by the enzyme concentration (0.032 M) to obtain an estimate of k cat .
Sequence Alignment and Analysis
The N-terminal regions of the known or putative CCA-adding enzymes from Bacillus subtilis (Bsu, Z99115), Escherichia coli (Eco, M12788), Arabidopsis thaliana (Ath, AC003979), Lupinus albus (Lal, U15930), Saccharomyces cerevisiae (Sce, M59870), Schizosaccharomyces pombe (Spo, AL049498), Rickettsia prowazekii (Rpr, AJ235270), Homo sapiens (Hsa, (AF151805), Caenorhabditis elegans (Cel, CAB02125), Mus musculus (Mmu, AK011764) and Drosophila melanogaster (Dme, AAF51964) were aligned according to the Smith and Waterman algorithm using a gap penalty of 10 and a gap extension penalty of 0.05 (Smith and Waterman, 1981; Thompson et al., 1994) . The sequence from Rickettsia prowazekii is classified as eubacterial poly(A) polymerases (PAP) based on sequence similarities with the corresponding protein from Bacillus subtilis. However, the Bacillus protein has been purified and characterized biochemically as a tRNA nucleotidyltransferase (Raynal et al., 1998) , and it is therefore likely that the putative PAP, identified as such by similarity to the Bacillus enzyme, is also a CCA-adding enzyme. Accordingly, it was included in the present study. For predicting the presence of a N-terminal mitochondrial targeting sequence the MITOPROT program at www.mips.biochem.mpg.de/proj/ medgen/mitop/ was used (Claros and Vincens, 1996) . The neighbor-joining tree was based on the distance matrix from the alignment in Figure 4 with 10 000 bootstrapping iterations (Saitou and Nei, 1987) .
